The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 18, Issue 8, Pages 1129-1136
Publisher
Oxford University Press (OUP)
Online
2016-07-06
DOI
10.1093/neuonc/now102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current trends in the management of glioblastoma in a French University Hospital and associated direct costs
- (2016) A. M. Henaine et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States
- (2015) Veena Shankaran et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
- (2015) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- First- and Second-Line Bevacizumab in Addition to Chemotherapy for Metastatic Colorectal Cancer: A United States–Based Cost-Effectiveness Analysis
- (2015) Daniel A. Goldstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme
- (2015) Bruno Kovic et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospects of immune checkpoint modulators in the treatment of glioblastoma
- (2015) Matthias Preusser et al. Nature Reviews Neurology
- Análisis coste-efectividad de la cirugía del glioma maligno guiada por fluorescencia con ácido 5-aminolevulínico
- (2015) J. Slof et al. NEUROLOGIA
- A Pilot Cost-Effectiveness Analysis of Treatments in Newly Diagnosed High-Grade Gliomas
- (2015) Susana Esteves et al. NEUROSURGERY
- A Cost Effectiveness Analysis of Nivolumab Compared to Ipilimumab for the Treatment of Braf Wild-Type Advanced Melanoma in Australia
- (2015) M Bohensky et al. VALUE IN HEALTH
- High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) R. Stupp et al. ANNALS OF ONCOLOGY
- Management of glioblastoma: comparison of clinical practices and cost-effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospital
- (2014) G. Diebold et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system
- (2014) Scott G Turner et al. World Journal of Surgical Oncology
- The cost-effectiveness of temozolomide in the adjuvant treatment of newly diagnosed glioblastoma in the United States
- (2013) A. Messali et al. NEURO-ONCOLOGY
- Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysis
- (2012) Victor Barzey et al. JOURNAL OF MEDICAL ECONOMICS
- A Trial-Based Assessment of the Cost-Utility of Bevacizumab and Chemotherapy versus Chemotherapy Alone for Advanced Non-Small Cell Lung Cancer
- (2011) Bernardo Goulart et al. VALUE IN HEALTH
- Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004
- (2010) L. Bauchet et al. NEURO-ONCOLOGY
- Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme
- (2008) Leida M. Lamers et al. CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now